The cytochrome P450 family member, Cyp2c40, stands as a pivotal player in the intricate landscape of arachidonic acid metabolism. This enzymatic entity is responsible for catalyzing arachidonic acid 11,12-epoxygenase and 14,15-epoxygenase activities, crucial processes that contribute to various physiological and pathological phenomena. Arachidonic acid, a polyunsaturated fatty acid, serves as a precursor for bioactive lipid mediators involved in diverse cellular responses, including inflammation, immune modulation, and vascular homeostasis. The epoxygenase activities of Cyp2c40, therefore, act as molecular switches, directing the fate of arachidonic acid and influencing downstream cellular pathways. The identified class of Cyp2c40 inhibitors presents a comprehensive understanding of the modulation of this cytochrome P450 member. These inhibitors, including both direct and indirect agents, intricately interfere with Cyp2c40's epoxygenase activities, disrupting the finely tuned balance of arachidonic acid metabolism. For instance, direct inhibitors like Fluconazole, Ritonavir, and Voriconazole specifically target either the 11,12- or 14,15-epoxygenase activities, reshaping the cellular responses associated with conditions linked to Cyp2c40.
The indirect inhibitors within this class, such as Metronidazole and Terbinafine, engage in the modulation of signaling pathways intricately connected to Cyp2c40. By influencing these pathways, these inhibitors contribute to the broader regulation of arachidonic acid metabolism, emphasizing the complexity of the cellular environment where Cyp2c40 operates. As key players in deciphering the molecular control points of Cyp2c40, this class of inhibitors serves as essential tools for researchers seeking to understand the fundamental aspects of arachidonic acid metabolism and its implications in health and disease. The nuanced insights found in the study of Cyp2c40 inhibitors lay the foundation for future investigations into the broader context of cytochrome P450-mediated cellular processes, contributing to the advancement of knowledge in the field of biochemistry and molecular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amodiaquine | 86-42-0 | sc-207282 | 10 mg | $342.00 | 1 | |
Amodiaquine, a direct inhibitor, perturbs the arachidonic acid metabolic process by specifically disrupting Cyp2c40's arachidonic acid 11,12-epoxygenase activity, altering key cellular responses. | ||||||
Fluconazole | 86386-73-4 | sc-205698 sc-205698A | 500 mg 1 g | $54.00 $84.00 | 14 | |
Fluconazole, another direct inhibitor, intricately modulates Cyp2c40's arachidonic acid 14,15-epoxygenase activity, reshaping the cellular landscape and influencing responses associated with conditions linked to Cyp2c40. | ||||||
Ritonavir | 155213-67-5 | sc-208310 | 10 mg | $124.00 | 7 | |
Ritonavir, a notable indirect inhibitor, engages in the regulation of signaling pathways intricately connected to Cyp2c40, exerting an influence on the arachidonic acid metabolic process and altering the cellular environment. | ||||||
Diclofenac Sodium | 15307-79-6 | sc-202136 sc-202136A | 5 g 25 g | $41.00 $128.00 | 4 | |
Diclofenac, acting as a direct inhibitor, specifically interferes with Cyp2c40's arachidonic acid 11,12-epoxygenase activity, thereby steering cellular responses related to the underlying pathophysiology. | ||||||
Miconazole | 22916-47-8 | sc-204806 sc-204806A | 1 g 5 g | $66.00 $160.00 | 2 | |
Miconazole, a direct inhibitor, exerts its influence on Cyp2c40's arachidonic acid 14,15-epoxygenase activity, reshaping the intricate landscape of cellular responses associated with conditions linked to Cyp2c40. | ||||||
Etodolac | 41340-25-4 | sc-204747 sc-204747A | 100 mg 250 mg | $89.00 $131.00 | 1 | |
Etodolac, a direct inhibitor, engages directly with Cyp2c40's arachidonic acid 11,12-epoxygenase activity, altering cellular responses and contributing to the modulation of conditions governed by Cyp2c40. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole, a direct inhibitor, intricately interferes with Cyp2c40's arachidonic acid 14,15-epoxygenase activity, reshaping the cellular landscape and influencing responses associated with conditions linked to Cyp2c40. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $42.00 $57.00 | 6 | |
Clotrimazole, acting as a direct inhibitor, specifically disrupts Cyp2c40's arachidonic acid 11,12-epoxygenase activity, altering key cellular responses and contributing to the modulation of conditions governed by Cyp2c40. | ||||||
Metronidazole | 443-48-1 | sc-204805 sc-204805A | 5 g 25 g | $84.00 $205.00 | 11 | |
Metronidazole, an indirect inhibitor, exerts its influence on signaling pathways intricately connected to Cyp2c40, contributing to the modulation of the arachidonic acid metabolic process and the cellular environment. | ||||||
Terbinafine | 91161-71-6 | sc-338609 | 100 mg | $560.00 | 1 | |
Terbinafine, a direct inhibitor, intricately modulates Cyp2c40's arachidonic acid 14,15-epoxygenase activity, reshaping the cellular landscape and influencing responses associated with conditions linked to Cyp2c40. | ||||||